Federal Register / Vol. 61, No. 111 / Friday, June 7, 1996 / Notices 29103

School Progress Survey—Respondents:

2,025; Average Burden per Response: 30

minutes; Total Burden for Child School

Progress Survey: 1012 hours—Total

Burden: 4,477 hours.

OMB Desk Officer: Allison Eydt

Copies of the information collection

packages listed above can be obtained

by calling the OS Reports Clearance

Officer on (202) 690–6207. Written

comments and recommendations for the

proposed information collection should

be sent directly to the OMB desk officer

designated above at the following

address: Human Resources and Housing

Branch, Office of Management and

Budget, New Executive Office Building,

Room 10235, 725 17th Street N.W.,

Washington, D.C. 20503.

Comments may also be sent to

Cynthia Agens Bauer, OS Reports

Clearance Officer, Room 503H,

Humphrey Building, 200 Independence

Avenue S.W., Washington DC, 20201.

Written comments should be received

within 30 days of this notice.

Dated: May 29, 1996.

Dennis P. Williams,

Deputy Assistant Secretary, Budget.

[FR Doc. 96–14398 Filed 6–6–96; 8:45 am]

BILLING CODE 4150–04–M

Public Health Service

National Institutes of Health

Submission for OMB Review;

Comment Request; National 5 A Day

for Better Health Follow-Up Survey

SUMMARY: Under the provisions of

Section 3506(c)(2)(A) of the Paperwork

Reduction Act of 1995, the National

Cancer Institute (NCI), the National

Institutes of Health (NIH) has submitted

to the Office of Management and Budget

(OMB) a request to review and approve

the information on collection listed

below. This proposed information

collection was previously published in

the Federal Register on March 12, 1996,

page 10001 and allowed 60-days for

public comment. No public comments

were received. The purpose of this

notice is to allow an additional 30 days

for public comment. The National

Institutes of Health may not conduct or

sponsor, and the respondent is not

required to respond to, an information

collection that has been extended,

revised, or implemented on or after

October 1, 1995, unless it displays a

currently valid OMB control number.

PROPOSED COLLECTION: Title: The

National 5 A Day for Better Health

Follow-up Study. Type of Information

Collection Request: NEW. Need and Use

of Information Collection: This study

will measure five year trends in fruit

and vegetable intakes and in knowledge,

attitudes, and beliefs about diet and

nutrition specific to fruit and vegetable

intake. The primary objectives of the

study are to establish current patterns in

fruit and vegetable consumption, beliefs

and fruit and vegetables and health,

program visibility and awareness, and

changes in these since baseline. The

findings will provide valuable

information concerning (1) the

effectiveness of the National 5 A Day for

Better Health Program in the first five

years of its existence, and (2) will be

used for program planning to help direct

further 5 A Day and other intervention

efforts. Frequency of Response: One

time. Affected Public: Individuals or

Households. Type of Respondents: U.S.

adults 18 years and older residing in

these coterminous states. The annual

reporting burden is as follows:

Type of respondents

Estimated

number of respondents

Estimated

number of responses per

respondent

Average burden

hours per response

Estimated total

annual burden

hours requested

Group 1 ........................................................................................................... 2000 1 .501 1002

Group 2 ........................................................................................................... 2050 1 .501 514

Non-Response ................................................................................................ 150 1 .167 25

Total ..................................................................................................... 4200 1 .3669 1541

The annualized cost to respondents is

estimated at: $12,410. There are no

Capital Costs to report. There are no

Operating to Maintenance Costs to

report.

REQUEST FOR COMMENTS: Written

comments and/or suggestions from the

public and affected agencies are invited

on one or more of the following points:

(1) Whether the proposed collection of

information is necessary for the proper

performance of the function of the

agency, including whether the

information will have practical utility;

(2) The accuracy of the agency’s

estimate of the burden of the proposed

collection of information, including the

validity of the methodology and

assumptions used; (3) Ways to enhance

the quality, utility, and clarity of the

information to be collected; and (4)

Ways to minimize the burden to the

collection of information on those who

are to respond, including the use of

appropriate automated, electronic,

mechanical, or other technological

collection techniques or other forms of

information technology.

DIRECT COMMENTS TO OMB: Written

comments and/or suggestions regarding

the item(s) contained in this notice,

especially regarding the estimated

public burden and associated response

time, should be directed to the: Office

of Management and Budget, Office of

Regulatory Affairs, New Executive

Office Building, Room 10235,

Washington, D.C. 20503, Attention:

Desk Officer for NIH.

To request more information on the

proposed project or to obtain a copy of

the data collection plans and

instruments, contact: Amy F. Subar,

Ph.D., Susan M. Krebs-Smith, Ph.D.,

National Cancer Institute, EPN 313,

6130 Executive Blvd, Bethesda, MD

20892–7344, or call non-toll-free

number (301) 496–8500.

COMMENTS DUE DATE: Comments

regarding this information collection are

best assured of having their full effect if

received within 30 days of the date of

this publication.

Dated: May 30, 1996.

Phillip D. Amoruso,

Executive Officer, NCI.

[FR Doc. 96–14430 Filed 6–6–96; 8:45 am]

BILLING CODE 4140–01–M

Office of the Secretary

Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

SUMMARY: Notice is hereby given that

the Office of Research Integrity (ORI)

has made final findings of scientific

misconduct in the following case:

Eric T. Fossel, Ph.D., Harvard Medical

School: Based on ORI’s analysis of the

relevant evidence and conclusions

submitted by the Harvard Medical
29104 Federal Register / Vol. 61, No. 111 / Friday, June 7, 1996 / Notices

School Committee on Faculty Conduct,

ORI found that Eric T. Fossel, Ph.D.,

former Harvard Medical School

Associate Professor of Radiology at Beth

Israel Hospital, committed scientific

misconduct by reporting falsified

research results in a Public Health

Service (PHS) grant application.

Specifically, Dr. Fossel altered

nuclear magnetic resonance (NMR) data

in the Multicenter Breast Trial (MCBT)

such that the NMR test, purporting to

detect from a patient’s blood sample a

predisposition toward malignancy or a

relapse, appeared to be more accurate,

sensitive, and specific than was actually

the case. Premised on these falsely

reported results, Dr. Fossel proposed in

a PHS grant application that the

National Cancer Institute provide funds

to complete the MCBT.

Dr. Fossel has entered into a

Voluntary Exclusion Agreement with

ORI in which he has voluntarily agreed,

for the three (3) year period beginning

May 9, 1996, to exclude himself from:

(1) any contracting or subcontracting

with any agency of the United States

Government and from eligibility for, or

involvement in, nonprocurement

transactions (e.g., grants and cooperative

agreements) of the United States

Government as defined in 45 CFR Part

76 (Debarment Regulations), and

(2) serving in any advisory capacity to

PHS, including but not limited to

service on any PHS advisory committee,

board, and/or peer review committee, or

as a consultant.

No scientific publications were

required to be corrected as part of this

Agreement.

FOR FURTHER INFORMATION CONTACT:

Director, Division of Research

Investigations, Office of Research

Integrity, 5515 Security Lane, Suite 700,

Rockville, MD 20852.

Chris B. Pascal,

Acting Director, Office of Research Integrity.

[FR Doc. 96–14389 Filed 6–6–96; 8:45 am]

BILLING CODE 4160–17–P

Centers for Disease Control and

Prevention

Disease, Disability, and Injury

Prevention and Control Special

Emphasis Panel (SEP): Teleconference

Meetings

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meetings.

Name: Disease, Disability, and Injury

Prevention and Control SEP: Cooperative

Agreements for Prevention Centers/National

Center for Chronic Disease Prevention and

Health Promotion—General Special Interest

Projects, Panel Number 1, Program

Announcements 328, 432, and 461.

Time and Date: 1 p.m.-5 p.m., June 24,

1996.

Place: National Center for Chronic Disease

Prevention and Health Promotion

(NCCDPHP), CDC, Rhodes Building, Koger

Office Park, 3005 Chamblee-Tucker Road,

Atlanta, Georgia 30341.

Status: Closed.

Matters To Be Discussed: The meeting will

include the review, discussion, and

evaluation of applications received in

response to Program Announcements 328,

432, and 461 entitled, ‘‘Cooperative

Agreements for Prevention Centers/

NCCDPHP—General Special Interest

Projects.’’

Contact Person for More Information:

James E. Barrow, Deputy Director, Division of

Adult and Community Health, NCCDPHP,

CDC, 4770 Buford Highway, NE, M/S K30,

Chamblee, Georgia 30341, telephone 770/

488–5269.

Name: Disease, Disability, and Injury

Prevention and Control SEP: Cooperative

Agreements for Prevention Centers Program/

NCCDPHP—General Special Interest Projects,

Panel Number 2, Program Announcements

328, 432, and 461.

Time and Date: 1 p.m.–5 p.m., June 25,

1996.

Place: NCCDPHP, CDC, Rhodes Building,

Koger Office Park, 3005 Chamblee-Tucker

Road, Atlanta, Georgia 30341.

Status: Closed.

Matters To Be Discussed: The meeting will

include the review, discussion, and

evaluation of applications received in

response to Program Announcements 328,

432, and 461 entitled, ‘‘Cooperative

Agreements for Prevention Centers/

NCCDPHP—General Special Interest

Projects.’’

Contact Person for More Information:

Michael N. Waller, Program Manager,

Division of Adult and Community Health,

NCCDPHP, CDC, 4770 Buford Highway, NE,

M/S K30, Chamblee, Georgia 30341,

telephone 770/488–5292.

Name: Disease, Disability, and Injury

Prevention and Control SEP: Cooperative

Agreements for Prevention Centers Program/

NCCDPHP—General Special Interest Projects,

Panel Number 3, Program Announcements

328, 432, and 461.

Time and Date: 1 p.m.–5 p.m., June 26,

1996.

Place: NCCDPHP, CDC, Rhodes Building,

Koger Office Park, 3005 Chamblee-Tucker

Road, Atlanta, Georgia 30341.

Status: Closed.

Matters To Be Considered: The meeting

will include the review, discussion, and

evaluation of applications received in

response to Program Announcements 328,

432, and 461 entitled, ‘‘Cooperative

Agreements for Prevention Centers/

NCCDPHP—General Special Interest

Projects.’’

Contact Person for More Information: Craig

L. Leutzinger, Public Health Advisor,

Division of Adult and Community Health,

NCCDPHP, CDC, 4770 Buford Highway, NE,

M/S K30, Chamblee, Georgia 30341,

telephone 770/488–5304.

These meetings will be closed to the public

in accordance with provisions set forth in

section 552b(c) (4) and (6), title 5 U.S.C., and

the Determination of the Associate Director

for Management and Operations, CDC,

pursuant to Pub. L. 92–463.

Dated: May 31, 1996.

John C. Burckhardt,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 96–14381 Filed 6–6–96; 8:45 am]

BILLING CODE 4163–18–M

Food and Drug Administration

Advisory Committee Meeting;

Cancellation

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is cancelling the

meeting of the Science Board to the

Food and Drug Administration

scheduled for June 13, 1996, to provide

time for the agency to continue its

development of strategies to address

toxicity, carcinogenicity, and

biomaterials testing. The meeting was

announced in the Federal Register of

May 24, 1996 (61 FR 26187).

FOR FURTHER INFORMATION CONTACT:

Susan A. Homire, Office of Science

(HF–33), Food and Drug

Administration, 5600 Fishers Lane,

Rockville, MD 20857, 301–827–3340; or

call the FDA Advisory Committee

Information Hotline, 1–800–741–8138

(301–443–0572) in the Washington, DC

area, Science Board to the Food and

Drug Administration, code 12603.

Dated: June 3, 1996.

Michael A. Friedman,

Deputy Commissioner for Operations.

[FR Doc. 96–14388 Filed 6–06–96; 8:45 am]

BILLING CODE 4160–01–F

Memorandum of Understanding

Between the Food and Drug

Administration and the U.S.

Department of Agriculture and the

Russian Federation

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is providing

notice of a memorandum of

understanding (MOU) between FDA and

the U.S. Department of Agriculture and